Perinatal outcomes in pregnant women with heart disease: Hospital General León experience


  • Edgar Ruiz Treviño Department of Gynecology and Obstetrics, General Hospital of León, Guanajuato, México
  • Gabriela Tecayehuatl Delgado Department of Gynecology and Obstetrics, General Hospital of León, Guanajuato, México
  • Junior Joel Araiza Navarro Deparment of Gynecology and Obstetrics, Centro Médico Naval, Postgraduate School in Naval Health, Coyoacán, Mexico



Adverse outcomes, Heart disease, Pregnancy


Background: Pregnancies in patients with heart disease are often complicated. The prevalence in our country is at 0.1 to 4%. An increase in the morbidity and mortality of pregnant patients with heart disease was observed, so it is recommended to evaluate the maternal risk with the WHO Classification. The objective of the study was to determine adverse outcomes; cardiac, obstetric and fetal/neonatal.

Methods: We retrospectively studied all pregnancies of women with heart disease that were presented on an outpatient basis in the period of 4 years at the General Hospital of León and maternal, obstetric and fetal/ neonatal outcomes were reviewed.

Results: In our study population, no maternal or fetal mortality was observed. Of 16 pregnancies of patients with heart disease were complicated by adverse cardiac events (2 of 16), obstetric (9 of 16), fetal/ neonatal (6 of 16). Hospitalization was required during the pregnancy of 11 patients. WHO class IV was the only group in which there were adverse cardiac events. 12 pregnancies were interrupted abdominally. Low fetal growth curve was observed in 6 of the 16 patients.

Conclusions: Pregnancies in patients with heart disease have a high risk of cardiac, obstetric and fetal / neonatal complications. Therefore, preconceptionally counseling and specialized multidisciplinary management should be offered to reduce perinatal morbidity and mortality.


Swan L. Congenital heart disease in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2014;28(4):495-506.

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cifkova R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Europe Heart J. 2018;39(34):3165-241.

Huisman CM, Zwart JJ, Roos-Hesselink JW, Duvekot JJ, van Roosmalen J. Incidence and predictors of maternal cardiovascular mortality and severe morbidity in The Netherlands: a prospective cohort study. PLoS One. 2013;8(2):e56494.

Rao S, Ginns JN. Adult congenital heart disease and pregnancy. Semin Perinatol. 2014;38(5):260-72.

van der Bom T, Bouma BJ, Meijboom FJ, Zwinderman AH, Mulder BJ. The prevalence of adult congenital heart disease, results from a systematic review and evidence-based calculation. Am Heart J. 2012;164(4):568-75.

Ntiloudi D, Zegkos T, Bazmpani MA, Parcharidou D, Panagiotidis T, Hadjimiltiades S, et al. Pregnacy outcome in women with congenital heart disease: A single-center experience. Hellenic J Cardiol. 2018;59(3):155-9.

López HC, Aguilar HE, Aguilar FD. Cardiopatía y embarazo. Ginecología y Obstetricia de México. 2006;74(03):153-7.

Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010;56(14):1149-57.

Hernández-Pacheco JA, Estrada-Altamirano A, Nares-Torices MÁ, Mendoza-Calderón SA, Orozco-Méndez H, Hernández-Muñoz VA, et al. Pronóstico materno y perinatal en mujeres embarazadas con cardiopatías congénitas con cortocircuito en el Instituto Nacional de Perinatología Isidro Espinosa de los Reyes. Perinatol Reprod Hum 2012;26(4): 137-46.

Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulat. 2014;130(9):749-56.

Ruys TP, Roos-Hesselink JW, Pijuan-Domènech A, Vasario E, Gaisin IR, Lung B et al. ROPAC investigators. Is a planned caesarean section in women with cardiac disease beneficial? Heart. 2015;101(7):530-6.

Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJ, et al. ZAHARA Investigators. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31(17):2124-32.

Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJ et al, ZAHARA Investigartors. Outocome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol. 2007;49(24):2303-11.

Regitz-Zagrosek V, Seeland U, Geibel-Zehender A, Gohlke-Bärwolf C, Kruck I, Schaefer C. Cardiovascular diseases in pregnancy. Dtsch Arztebl Int. 2011;108(16):267-73.

Maternal cardiopathy and pregnancy, Protocol, Clinic Barcelona, 2018.

Garnica-Camacho CE. Congenital heart disease in pregnant women: approach of the internist doctor. Med Int. 2016 ;32(4):436-45.

Diagnosis and Management of Cardiopathy in Pregnancy, Evidence and Recommendations, CENETEC, Master Catalog of Clinical Practice Guidelines, IMSS-538-11.






Original Research Articles